secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001493152-25-029018
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix amends CEO contract with 9% equity grant; appoints interim CFO
---------------------------------------------------------------------------

- CEO Doron Besser new base salary $360K, bonus up to $180K; severance of 12 months' base salary on change-of-control termination.
- Besser receives 180,000 RSUs (9% of outstanding common stock) plus annual grants to maintain 9% equity.
- CFO Stephen Brown departed Dec. 18, 2025; Nicole Fernandez-McGovern appointed Interim CFO via consulting agreement with RCM Financial Consulting.
- Fernandez-McGovern receives $300K annual salary; served as CFO of NLS Pharmaceutics and interim CFO of Hayden AI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225029018/0001493152-25-029018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315225029018/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-029018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer